Trademark: 88957964
Status Date
Monday, November 20, 2023
Filing Date
Wednesday, June 10, 2020
Published for Opposition
Tuesday, August 25, 2020
Abandoned Date
Monday, November 20, 2023
9 Scientific equipment, apparatus and instruments, namely, genome sequencer for scientific, pharmaceutical and medical research purposes; scientific instruments for use in scientific research, namely, nucleic acid sequencers, imaging devices and analyzers; laboratory apparatus for sample preparation, amplification, mixing, hybridization, incubation, and washing, namely, arrays, beads, bead sets and flow cells; laboratory equipment, namely, devices for analysis of nucleic acids and for dna sequencing; automated laboratory apparatus and systems, namely, sample loaders and bar code readers; downloadable software used for genotyping and gene expression microarrays for scientific, pharmaceutical and medical research purposes; downloadable software used in analyzing, managing and visualizing dna sequencing data; downloadable software used for preparation of nucleic acids libraries; computer hardware and downloadable software for collecting, storing, analyzing and reporting biological information, and for sample tracking and managing projects, laboratory workflow and data, for use in the fields of scientific, diagnostic and clinical research and for clinical diagnostic purposes
5 In vitro diagnostic agents, namely, reagents and control solutions for analysis of biological samples, all for medical diagnostic purposes; reagents for medical diagnostic use; medical diagnostic assays and reagents for testing of biological samples; reagent kits consisting of enzymes, oligonucleotides, nucleic acids, natural and modified nucleotides, buffers, labels, and substrates for medical diagnostic purposes; medical diagnostic test kits comprising reagents for testing body fluids to determine fetal chromosomal abnormalities; chemical reagents, preparations and test kits for fetal nucleic acid analysis for medical use; diagnostic kits consisting primarily of reagents for nucleic acid detection and analysis for medical diagnostic purposes; reagents for medical diagnostic use and diagnostic kits comprised of medical diagnostic reagents and assays for use in connection with dna sequencing and genetic analysis
1 In vitro diagnostic agents, namely, chemical control solutions for calibrating and monitoring the accuracy and function of instruments and test results, chemical additives, enzymes, reagents, organisms and proteins for use in science, research and industry; reagents for cell separation for scientific or research purposes; labeling reagents for scientific or research purposes; reagents for the processing, separation, isolation, enrichment, depletion, detection, screening, cultivation, analysis and counting of material, in particular of chemicals and biological material, all for scientific or research purposes; reagents featuring magnetic beads for scientific or research purposes; antibody reagents for scientific or research purposes; buffer solutions and reagents for use with laboratory apparatus, namely, separation apparatus and analysis apparatus, for scientific or research purposes; reagents for processing biological material, namely, tissue, bone marrow, cells, blood and components thereof for scientific or research purposes; reagents, enzymes, and nucleotides for nucleic acid sequencing for scientific or research purposes; diagnostic tests comprised of reagents and chemical test kits for determination of genetic information for scientific or research purposes; reagents for scientific or medical research use for analyzing cells, proteins, nucleic acids, sequencing dna, genotyping, gene expression profiling and high through-put screening; reagent kits composed primarily of oligonucleotides, enzymes and buffers for nucleic acid detection in the fields of scientific, pharmaceutical and medical research; nucleic acids, enzymes, buffers and chemical reagents for use in genotyping and gene expression test kits for detecting and analyzing nucleic acids for scientific or research purposes; assays and reagents for scientific or medical research use; diagnostic tests and test kits primarily composed of reagents and nucleotides for determination of genetic information for scientific or research purposes; reagents and chemical test kits for scientific and research use in connection with dna sequencing and genetic analysis
Nov 20, 2023
Abandonment Notice E-Mailed - No Use Statement Filed
Nov 20, 2023
Abandonment - No Use Statement Filed
Apr 13, 2023
Notice Of Approval Of Extension Request E-Mailed
Apr 12, 2023
Sou Extension 5 Granted
Apr 5, 2023
Sou Extension 5 Filed
Apr 12, 2023
Case Assigned To Intent To Use Paralegal
Apr 5, 2023
Sou Teas Extension Received
Oct 5, 2022
Notice Of Approval Of Extension Request E-Mailed
Oct 3, 2022
Sou Extension 4 Granted
Oct 3, 2022
Sou Extension 4 Filed
Oct 3, 2022
Sou Teas Extension Received
Apr 6, 2022
Notice Of Approval Of Extension Request E-Mailed
Apr 4, 2022
Sou Extension 3 Granted
Apr 4, 2022
Sou Extension 3 Filed
Apr 4, 2022
Sou Teas Extension Received
Oct 20, 2021
Notice Of Approval Of Extension Request E-Mailed
Oct 18, 2021
Sou Extension 2 Granted
Oct 18, 2021
Sou Extension 2 Filed
Oct 18, 2021
Sou Teas Extension Received
Apr 7, 2021
Notice Of Approval Of Extension Request E-Mailed
Apr 5, 2021
Sou Extension 1 Granted
Apr 5, 2021
Sou Extension 1 Filed
Apr 5, 2021
Sou Teas Extension Received
Oct 20, 2020
Noa E-Mailed - Sou Required From Applicant
Oct 19, 2020
Applicant/Correspondence Changes (Non-Responsive) Entered
Oct 19, 2020
Teas Change Of Correspondence Received
Oct 19, 2020
Attorney/Dom.Rep.Revoked And/Or Appointed
Oct 19, 2020
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Oct 19, 2020
Teas Change Of Owner Address Received
Aug 25, 2020
Official Gazette Publication Confirmation E-Mailed
Aug 25, 2020
Published For Opposition
Aug 5, 2020
Notification Of Notice Of Publication E-Mailed
Jul 23, 2020
Approved For Pub - Principal Register
Jul 22, 2020
Teas/Email Correspondence Entered
Jul 22, 2020
Correspondence Received In Law Office
Jul 22, 2020
Teas Response To Office Action Received
Jul 18, 2020
Notification Of Non-Final Action E-Mailed
Jul 18, 2020
Non-Final Action E-Mailed
Jul 18, 2020
Non-Final Action Written
Jul 18, 2020
Notification Of Non-Final Action E-Mailed
Jul 18, 2020
Non-Final Action E-Mailed
Jul 18, 2020
Non-Final Action Written
Jul 17, 2020
Previous Allowance Count Withdrawn
Jul 17, 2020
Approved For Pub - Principal Register
Jul 16, 2020
Assigned To Examiner
Jul 7, 2020
New Application Office Supplied Data Entered
Jun 13, 2020
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
